Stay updated with breaking news from Sientra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SANTA BARBARA, Calif., Sept. 20, 2022 -- Sientra, Inc. , a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced today that it has received... | September 21, 2022
Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery,
Wall Street brokerages expect Sientra, Inc. (NASDAQ:SIEN – Get Rating) to report ($0.23) earnings per share for the current quarter, Zacks reports. Two analysts have issued estimates for Sientra’s earnings, with estimates ranging from ($0.24) to ($0.22). Sientra reported earnings per share of ($0.22) during the same quarter last year, which would indicate a negative […]
Equities analysts expect Sientra, Inc. (NASDAQ:SIEN – Get Rating) to announce earnings of ($0.26) per share for the current quarter, according to Zacks. Two analysts have made estimates for Sientra’s earnings, with the highest EPS estimate coming in at ($0.25) and the lowest estimate coming in at ($0.27). Sientra posted earnings of ($0.10) per share […]
Sientra (NASDAQ:SIEN – Get Rating) had its price target trimmed by UBS Group from $10.00 to $8.00 in a research note issued to investors on Tuesday, The Fly reports. The firm currently has a buy rating on the medical instruments supplier’s stock. SIEN has been the topic of a number of other research reports. Colliers […]
Shares of Sientra, Inc. (NASDAQ:SIEN – Get Rating) have been given an average recommendation of “Buy” by the eight research firms that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating and six have given a buy rating to the company. The average 1-year price […]
Sientra (NASDAQ:SIEN – Get Rating) and Cadre (NYSE:CDRE – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, valuation and dividends. Valuation and Earnings This table compares Sientra and Cadre’s revenue, earnings […]
Sientra (NASDAQ:SIEN – Get Rating) issued its earnings results on Wednesday. The medical instruments supplier reported ($0.27) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.08), MarketWatch Earnings reports. During the same period last year, the company posted ($0.38) EPS. Sientra updated its FY 2022 guidance to EPS. Shares of SIEN […]